Eppendorf Research plus is the first pipette to receive My Green Lab ACT label

The Eppendorf Research® plus single-channel pipette line-up with variable volume has been certified with an “ACT®” Environmental Impact Factor Label by the “My Green Lab®” non-profit organization. By emphasizing Accountability, Consistency, and Transparency (ACT) around manufacturing, energy and water use, packaging, and end-of-life, the ACT label makes it easier for labs to choose more sustainable [...]

Westlake Omics Authorized as the Exclusive Distributor and Service Provider of Pressure BioSciences, Inc. in China

HANGZHOU, China -- The Agreement signed by Westlake Omics (Hangzhou) Biotechnology Co., Ltd (hereinafter referred to as Westlake Omics) and Pressure BioSciences, Inc. (hereinafter referred to as PBI) on December 3, 2021 authorized Westlake Omics as the exclusive distributor and service provider for PBI's PCT Sample Preparation System Platform and related products in China, a move that enables Westlake [...]

Notice Concerning Reorganization of Scientific Solutions Business through Company Split (Simple Absorption-type Split)

Company: Olympus Corporation Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi (Code: 7733, First Section, Tokyo Stock Exchange) Contact: Takaaki Sakurai, Vice President, Investor Relations Olympus Corporation ("Olympus") hereby announces that our board of directors has resolved at a meeting held today to transfer our scientific solutions business through an absorption-type company split (the [...]

Notice Concerning Reorganization of Scientific Solutions Business through Company Split (Simple Absorption-type Split)

Company: Olympus Corporation Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi (Code: 7733, First Section, Tokyo Stock Exchange) Contact: Takaaki Sakurai, Vice President, Investor Relations Olympus Corporation ("Olympus") hereby announces that our board of directors has resolved at a meeting held today to transfer our scientific solutions business through an absorption-type company split (the [...]

Services to Accelerate Genome Editing Research

AMSBIO has expanded its range of custom gene editing services to complement its extensive portfolio of off-the-shelf CRISPR/Cas9 products. A powerful technology, widely used in genome science, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) / Cas9 is a simple and efficient editing tool which allows for specific genome disruption and replacement facilitating the manipulation of [...]

Nodexus Inc. Emerges from Stealth with $30 Million Series A Funding to Advance Manufacturing and Expand Commercialization of NX One Platform

The NX One platform is the first universally adoptable system to characterize, sort, and isolate single cells from biological samples Industry veteran William Rhodes joins Board of Directors SAN JOSE, Calif. -- Nodexus Inc., an emerging leader in the development of automated live cell characterization and isolation technologies, has raised an oversubscribed $30M Series A [...]

Renowned Physician-Scientist Brings Significant Expertise as a Pioneer in the Fields of Leukemia Research and Molecular Genetics

TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that internationally renowned physician-scientist Jerald Radich, M.D., a pioneer in the fields of leukemia research and molecular genetics, has joined HTG’s Therapeutics Scientific Advisory Board. Dr. Radich adds to the company’s [...]

Nicoya Extends Series A Financing With Additional $20 M to Meet Demand of Rapidly Growing Proteomics Industry

Nicoya’s Series A Extension is led by Whitecap Venture Partners, with participation from industry leader Agilent Technologies Inc (NYSE: A) KITCHENER, Ontario--Nicoya Lifesciences, a global leader in digital proteomics solutions, today announced a $20 million Series A extension led by Whitecap Venture Partners. The round included participation from strategic investor Agilent Technologies, a leading global [...]

Inventia Life Science Accelerates Growth with AU$35 million Series B Led by Blackbird Ventures, Launching 3D Cell Culture Platform into US Market

Company aims to democratise access to affordable biomedical research especially in cancer research and new drug development through its novel 3D cell culture platform Sydney, Australia — Inventia Life Science, a world leader in advanced 3D cell cultures for research and clinical purposes, has today announced the close of a AU$35m Series B funding round, led by Blackbird [...]

BIONANO GENOMICS ANNOUNCES THE LAUNCH OF VERSION 6.1 OF BIODISCOVERY’S NXCLINICAL SOFTWARE FOR GENOME ANALYSIS WITH EXPANDED CAPABILITIES FOR VISUALIZATION, INTERPRETATION AND REPORTING OF NEXT-GENERATION SEQUENCING DATA IN GENETIC DISEASES AND CANCER

SAN DIEGO -- Bionano Genomics, Inc. (BNGO), provider of optical genome mapping (OGM) solutions on the Saphyr® system and the leading software for genomic data visualization, interpretation and reporting, today announced the launch of version 6.1 of BioDiscovery’s NxClinical software with expanded capabilities for next-generation sequencing (NGS) data in genetic diseases and cancer. NxClinical is an [...]

Access IBO on Knowledge Center